Home/Filings/4/0000950170-24-131890
4//SEC Filing

Baker Daniel G. 4

Accession 0000950170-24-131890

CIK 0001645460other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 4:00 PM ET

Size

5.5 KB

Accession

0000950170-24-131890

Insider Transaction Report

Form 4
Period: 2024-11-25
Baker Daniel G.
CHIEF DEVELOPMENT OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2024-11-25+200,000200,000 total
    Exercise: $1.06Exp: 2034-11-24Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Represents an inducement stock option granted on November 25, 2024.
  • [F2]This stock option will become exercisable over two years in equal, semi-annual installments beginning on May 25, 2025.

Documents

1 file

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0002046802

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 4:00 PM ET
Size
5.5 KB